PlexusDx operates independently of insurance networks and serves all 50 states without requiring insurance coverage or membership fees
We have to be working at every level to mitigate or reduce current risks
Suckfull M, Althaus M, Ellers-Lenz B, et al
Over the past year, youll have noticed GLP-1 popping up in headlines, social media posts and conversations about weight loss
A phase Ib trial with a 4-week subcutaneous administration of either 10 mg or 15 mg tirzepatide once weekly in subjects with T2D led to a significant reduction in fasting plasma glucose concentrations (LSM difference [95% CI]: 49.12 mg/dl [78.14, 20.12] and 43.15 mg/dl [73.06, 13.21], respectively) and to reductions in body weight (LSM difference [95% CI]: 2.62 kg [3.79, 1.45] and 2.07 kg [3.25, 0.88], respectively